SBWire

According to some fresh reports in and around the country, several cases have been filed questioning the Zofran prescription for pregnant women. In one of the Zofran lawsuits, the anti-nausea drug has been blamed for heart defects and other congenital deformities borne by the babies exposed to Zofran in the uterus.

Testosterone levels are declining. Many theories exist as to why, but as generations go by, men are being born with lower starting levels of testosterone, and their levels of the hormone are falling earlier and more dramatically than ever before. As such, there is an increasing need for ways to mediate this problem on behalf of sufferers, as low testosterone not only affects the body and mind, but comes with serious health risks. HealthMenLibido.com is a website dedicated to helping people increase their testosterone, and has discovered a new, herbal means by which to increase levels naturally.

Advanced Accelerator Applications S.A. ("AAA" or "The Company"), an international specialist in Molecular Nuclear Medicine (MNM), today announced its financial results for the first quarter of 2015.

Founded in 1992, The PennTech Machinery Corporation manufactures the highest-quality products for pharmaceutical sterilization and aseptic pharmaceutical processing. They provide a wide variety of products with an assortment of sterilization levels for pharmaceutical companies and other businesses performing scientific research. Currently, PennTech Machinery Corporation is announcing their availability to manufacture new equipment for aseptic pharmaceutical processing nationwide.

Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced that the presentation of poster and abstract at ASCO 2015, the 51stAnnual Meeting of American Society of Clinical Oncology, was given in Chicago on May 31. Data from the Company's ongoing multi-center Phase 1/2 Study for Actimab-A for the treatment of newly diagnosed Acute Myeloid Leukemia (AML) in elderly patients were presented by Dr. Joseph Jurcic of Columbia University Medical Center, Actinium's Clinical Advisory Board Chairman.

CEL-SCI Corporation("CEL SCI" or the "Company") today announced that Spain's Agency for Medicinal Products and Medicinal Devices has authorized the Company to commence patient enrollment for its ongoing Phase 3 trial of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) in patients with advanced primary squamous cell carcinoma of the oral cavity/soft palate, a type of head and neck cancer. Spain is the 22nd country to authorize CEL-SCI's Phase 3 trial for patient enrollment.

Maintaining their name as one of the leading clinical research organization in the Indian Ocean, Insight Research continues their growth. Clinical studies are being set up in compliance to international and local standards as well as Good Clinical Practice.

There are few industries in the world that consumers rely on more for absolute preciseness than the pharmacological industry. This is not a question of quality or taste, but can be a matter of life or death for the patient receiving any medication that has been improperly mixed or contaminated. In many cases this happens not because of an intent to do harm but due to improper sterilization methods. White Mountain Process wants these issues to no longer be a concern for either the companies or consumers. That is why they are doing everything they can to boost awareness of their mixing equipment, designed to help eliminate these worries.

SG Bio Pharm, the popular pharmaceutical tablet manufacturers in India, follows all new rigorous quality assurance processes in order to provide customers with the highest quality medication. The pharmacy makes use of highly reliable quality assurance process that enables them to supply medications at international standards.

Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) innovuspharma.com (OTCQB:INNV) a company focusing on the commercialization of over-the-counter ("OTC") and consumer products for men's and women's health, vitality and respiratory diseases announced today that its partner Sothema Laboratories, ("Sothema") received marketing authorization for Zestra® in the United Arab Emirates (the "UAE").

Gibraltar Laboratories, Inc. is a Contract Research Organization (CRO) with a headquarters in Pine Brook, New Jersey and laboratories in Fairfield, New Jersey. The Gibraltar facility is one of only a few facilities nominated for the prestigious ISPE 2015 Facility of the Year. For 2015 they are reminding both new and returning clientele of the importance of bioburden testing for medical devices as well as pharmaceutical products including injectables and more. Controlling the bioburden optimizes delivery of the appropriate sterilization services dose.

PennTech Machinery Corporation (PennTech) provides aseptic manufacturing equipment as well as other products related to depyrogenation and sterilization. They are currently announcing that they desire to help pharmaceutical organizations achieve compliance with strict sterilization validation standards by providing them with high end sterilization, depyrogenation and aseptic pharmaceutical processing equipment.

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing protein biologic therapies and oncology supportive care products, announced today it had appointed Charlie Strange, M.D. to its Scientific Advisory Board (SAB). Dr. Strange is a highly regarded thought leader in the Alpha-1 community, and has extensive clinical experience in designing and managing Alpha-1 clinical studies. The Company believes his advice and counsel will help accelerate development and approval of its proprietary SDF Alpha(TM) biologic drug.

CEL-SCI Corporation today announced that Aintree University Hospital, in Liverpool, England, has become a clinical site for the Company's global pivotal Phase III head and neck cancer trial for its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection). This is the first center to join the Multikine Phase III study in the UK.

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing protein biologic therapies and oncology supportive care products, appointed Robert Sandhaus, MD, Ph.D. to its Scientific Advisory Board (SAB). The appointed SAB will serve as a strategic resource to the company as it continues to develop and commercialize its proprietary plasma fractionation platform, Salt Diafiltration Process (SDF™), and its lead biologic candidate, SDF Alpha, its proprietary alpha-1 protease inhibitor (A1PI).

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing protein biologic therapies and oncology supportive care products, announced today that its Korean marketing partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: 128940) has received marketing approval in Korea from the country's Ministry of Food and Drug Safety ("MFDS") and the Korea Testing & Research Institute (KTR) for MuGard, its oncology supportive-care treatment for the management of oral mucositis. Under the terms of the previously announced marketing agreement, Hanmi will import MuGard from the United States and marketing will commence. Hanmi intends to market MuGard in Korea under the trade name Mucogard.

System Analytic today launched a revolutionary type of Key Opinion Leader Profiling, called "Live KOL Profiles".

Hytrol Conveyor Company with Integration Partner, Bastion Solutions, just released important data in a new pharmaceutical report. One of the industry leaders, Roche Diagnostics Operations (RDO) improve operations by standardizing processes across all warehouses and implementing an automated material handling system. Roche increased pack rates, reduced operating costs, and gained better visibility of carton-level details.

EASY DRUG CARD today announced a new iPhone and Android app that allows users to access its discount pharmacy network and drug pricing tool via an app. This gives users the ability to reap significant savings on prescription medications at local pharmacies across the country. The new EasyDrugCard app, developed by Reinvolve of Colorado Springs, is a free mobile application designed with easy-to-use navigation of its drug pricing tool, pharmacy locator, FAQs, and discount card information. The new app is immediately available to the entire community of uninsured, under-insured or any individuals that currently pay full price for their medications.

PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company advancing protein biologic therapies and oncology supportive care products, has a new presentation slot at the 27th Annual ROTH Capital Partners Conference which is being held on March 8-11, 2015, at The Ritz-Carlton, Laguna Niguel in Dana Point, California.

As part of American Heart Month, Feb. 6 has been dubbed National Wear Red Day. It was created to acknowledge the one in three women every year whose deaths are related to stroke and heart disease. Prescription medicines are often used in the front lines against this epidemic. Medicationdiscountcard.com offers discount cards for many of these prescriptions.

DelMar Pharmaceuticals, Inc. (DMPI) (DelMar and the Company), a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, today announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application number 13/817,096 entitled, "Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol."

SIGNiX, the leading provider of Independent E-Signatures™, announced today that it has launched PharmaDoX, the pharmaceutical industry's first digital signature service created to relieve paperwork burdens of clinical trials. PharmaDoX makes it easy for sponsors, clinical research organizations (CROs), investigators and patients to sign clinical trial documents online while adhering to FDA regulations. This ready-made solution incorporates the requirements of the FDA's 21 CFR Part 11 rule.

Manzo Pharmaceuticals, Inc. (OTCPink:MNZO), today announced positive results from the six month animal study of Lacto-Freedom™, the company's lactase producing probiotic. This successful testing brings Manzo Pharmaceuticals, and partner, Celprogen, Inc., one step closer to human clinical trials.

FyMed is advancing targeted candidates for both early and advanced colorectal cancer. FY405B is an investigational cancer targeted cytotoxic therapy, a new class of treatments that use the body's own selective pathways to help fight cancer. FyMed has developed substantial preclinical evidence that its drug candidate, FY405B, could effectively kill colon cancer cells through in-vitro studies as well as in animal models of colon cancer.